Stable Istotope Labelled Tremelimumab Biosimilar – Anti-CTLA4/CD152 mAb – Research Grade

Reference: PX-TA1177-SIL-1MG
Product nameStable Istotope Labelled Tremelimumab Biosimilar - Anti-CTLA4/CD152 mAb - Research Grade
SourceCAS 745013-59-6
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsTicilimumab, CP-675,CP-675,206,CP-675206 clone 11.2.1
ReferencePX-TA1177-SIL
Related ProductsPX-P4361
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-CTLA4/CD152(Homo sapiens) (Tremelimumab) Monoclonal Antibody

Tremelimumab is studied for the treatment of Mesothelioma, Liver Neoplasms, Liver Cancer, Liver Cell Caricinoma, and HepatoCellular Carcinoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Tremelimumab Biosimilar – Anti-CTLA4/CD152 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.